680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) 2024-08, Vol.191 (Supplement_2)
Main Authors: Zirwas, Matthew J, Boguniewicz, Mark, Rosmarin, David, Fuxench, Zelma Chiesa, Warren, Richard B, Torres, Tiago, de Bruin-Weller, Marjolein, Dawson, Zach, Atwater, Amber Reck, Elmaraghy, Hany, Pierce, Evangeline, Bardolet, Laia, Zhong, Jinglin, Armstrong, April W
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue Supplement_2
container_start_page
container_title British journal of dermatology (1951)
container_volume 191
creator Zirwas, Matthew J
Boguniewicz, Mark
Rosmarin, David
Fuxench, Zelma Chiesa
Warren, Richard B
Torres, Tiago
de Bruin-Weller, Marjolein
Dawson, Zach
Atwater, Amber Reck
Elmaraghy, Hany
Pierce, Evangeline
Bardolet, Laia
Zhong, Jinglin
Armstrong, April W
description
doi_str_mv 10.1093/bjd/ljae266.054
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_bjd_ljae266_054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_bjd_ljae266_054</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1093_bjd_ljae266_0543</originalsourceid><addsrcrecordid>eNqVkE1OwzAQhS0EEuFnzXYu4HZck0DZoiIOwN6aOBPq4MSR7VKFq3BZXKkXYPVm3mienj4hHhSuFG71uh26tR-IN02zwvrxQlRKN7XcKK0vRYWITxK3jb4WNykNiEpjjZX4bZ4RJOz63lmyC4QePLfRfbmfw0gtuAmoO_icgKaujMFzsjyV_ejyHsbQcaTMMgeZ-JsjA-UwOwvFHym77BK0C9Ann6LDlDi_lCjySyqXYuVjgHlPiUGD9W4qNTzk6MinO3HVF-H7s96K9dvu4_Vd2hhSitybObqR4mIUmhMDUxiYMwNTGOj_f_wB5TNpKA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials</title><source>Oxford Journals Online</source><creator>Zirwas, Matthew J ; Boguniewicz, Mark ; Rosmarin, David ; Fuxench, Zelma Chiesa ; Warren, Richard B ; Torres, Tiago ; de Bruin-Weller, Marjolein ; Dawson, Zach ; Atwater, Amber Reck ; Elmaraghy, Hany ; Pierce, Evangeline ; Bardolet, Laia ; Zhong, Jinglin ; Armstrong, April W</creator><creatorcontrib>Zirwas, Matthew J ; Boguniewicz, Mark ; Rosmarin, David ; Fuxench, Zelma Chiesa ; Warren, Richard B ; Torres, Tiago ; de Bruin-Weller, Marjolein ; Dawson, Zach ; Atwater, Amber Reck ; Elmaraghy, Hany ; Pierce, Evangeline ; Bardolet, Laia ; Zhong, Jinglin ; Armstrong, April W</creatorcontrib><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1093/bjd/ljae266.054</identifier><language>eng</language><ispartof>British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Zirwas, Matthew J</creatorcontrib><creatorcontrib>Boguniewicz, Mark</creatorcontrib><creatorcontrib>Rosmarin, David</creatorcontrib><creatorcontrib>Fuxench, Zelma Chiesa</creatorcontrib><creatorcontrib>Warren, Richard B</creatorcontrib><creatorcontrib>Torres, Tiago</creatorcontrib><creatorcontrib>de Bruin-Weller, Marjolein</creatorcontrib><creatorcontrib>Dawson, Zach</creatorcontrib><creatorcontrib>Atwater, Amber Reck</creatorcontrib><creatorcontrib>Elmaraghy, Hany</creatorcontrib><creatorcontrib>Pierce, Evangeline</creatorcontrib><creatorcontrib>Bardolet, Laia</creatorcontrib><creatorcontrib>Zhong, Jinglin</creatorcontrib><creatorcontrib>Armstrong, April W</creatorcontrib><title>680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials</title><title>British journal of dermatology (1951)</title><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVkE1OwzAQhS0EEuFnzXYu4HZck0DZoiIOwN6aOBPq4MSR7VKFq3BZXKkXYPVm3mienj4hHhSuFG71uh26tR-IN02zwvrxQlRKN7XcKK0vRYWITxK3jb4WNykNiEpjjZX4bZ4RJOz63lmyC4QePLfRfbmfw0gtuAmoO_icgKaujMFzsjyV_ejyHsbQcaTMMgeZ-JsjA-UwOwvFHym77BK0C9Ann6LDlDi_lCjySyqXYuVjgHlPiUGD9W4qNTzk6MinO3HVF-H7s96K9dvu4_Vd2hhSitybObqR4mIUmhMDUxiYMwNTGOj_f_wB5TNpKA</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>Zirwas, Matthew J</creator><creator>Boguniewicz, Mark</creator><creator>Rosmarin, David</creator><creator>Fuxench, Zelma Chiesa</creator><creator>Warren, Richard B</creator><creator>Torres, Tiago</creator><creator>de Bruin-Weller, Marjolein</creator><creator>Dawson, Zach</creator><creator>Atwater, Amber Reck</creator><creator>Elmaraghy, Hany</creator><creator>Pierce, Evangeline</creator><creator>Bardolet, Laia</creator><creator>Zhong, Jinglin</creator><creator>Armstrong, April W</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240808</creationdate><title>680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials</title><author>Zirwas, Matthew J ; Boguniewicz, Mark ; Rosmarin, David ; Fuxench, Zelma Chiesa ; Warren, Richard B ; Torres, Tiago ; de Bruin-Weller, Marjolein ; Dawson, Zach ; Atwater, Amber Reck ; Elmaraghy, Hany ; Pierce, Evangeline ; Bardolet, Laia ; Zhong, Jinglin ; Armstrong, April W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1093_bjd_ljae266_0543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zirwas, Matthew J</creatorcontrib><creatorcontrib>Boguniewicz, Mark</creatorcontrib><creatorcontrib>Rosmarin, David</creatorcontrib><creatorcontrib>Fuxench, Zelma Chiesa</creatorcontrib><creatorcontrib>Warren, Richard B</creatorcontrib><creatorcontrib>Torres, Tiago</creatorcontrib><creatorcontrib>de Bruin-Weller, Marjolein</creatorcontrib><creatorcontrib>Dawson, Zach</creatorcontrib><creatorcontrib>Atwater, Amber Reck</creatorcontrib><creatorcontrib>Elmaraghy, Hany</creatorcontrib><creatorcontrib>Pierce, Evangeline</creatorcontrib><creatorcontrib>Bardolet, Laia</creatorcontrib><creatorcontrib>Zhong, Jinglin</creatorcontrib><creatorcontrib>Armstrong, April W</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zirwas, Matthew J</au><au>Boguniewicz, Mark</au><au>Rosmarin, David</au><au>Fuxench, Zelma Chiesa</au><au>Warren, Richard B</au><au>Torres, Tiago</au><au>de Bruin-Weller, Marjolein</au><au>Dawson, Zach</au><au>Atwater, Amber Reck</au><au>Elmaraghy, Hany</au><au>Pierce, Evangeline</au><au>Bardolet, Laia</au><au>Zhong, Jinglin</au><au>Armstrong, April W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials</atitle><jtitle>British journal of dermatology (1951)</jtitle><date>2024-08-08</date><risdate>2024</risdate><volume>191</volume><issue>Supplement_2</issue><issn>0007-0963</issn><eissn>1365-2133</eissn><doi>10.1093/bjd/ljae266.054</doi></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)
issn 0007-0963
1365-2133
language eng
recordid cdi_crossref_primary_10_1093_bjd_ljae266_054
source Oxford Journals Online
title 680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A14%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=680%20-%20Efficacy%20of%20lebrikizumab%20in%20adults%20and%20adolescents%20with%20moderate-to-severe%20atopic%20dermatitis%20by%20age%20of%20onset:%20analysis%20of%20two%20phase%203%20clinical%20trials&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Zirwas,%20Matthew%20J&rft.date=2024-08-08&rft.volume=191&rft.issue=Supplement_2&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1093/bjd/ljae266.054&rft_dat=%3Ccrossref%3E10_1093_bjd_ljae266_054%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_1093_bjd_ljae266_0543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true